Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Deferred Taxes (2016 - 2024)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Deferred Taxes data on record, last reported at $109000.0 in Q4 2024.

  • For Q4 2024, Deferred Taxes rose 372.5% year-over-year to $109000.0; the TTM value through Nov 2024 reached $136000.0, down 66.5%, while the annual FY2024 figure was $163000.0, 54.34% down from the prior year.
  • Deferred Taxes reached $109000.0 in Q4 2024 per LFCR's latest filing, up from -$100000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $2.4 million in Q2 2020 and bottomed at -$5.3 million in Q1 2020.
  • Average Deferred Taxes over 5 years is -$850250.0, with a median of -$82000.0 recorded in 2024.
  • The widest YoY moves for Deferred Taxes: up 559.73% in 2020, down 1774.2% in 2020.
  • A 5-year view of Deferred Taxes shows it stood at -$2.7 million in 2020, then dropped by 3.86% to -$2.8 million in 2021, then skyrocketed by 100.14% to $4000.0 in 2022, then crashed by 1100.0% to -$40000.0 in 2023, then surged by 372.5% to $109000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Deferred Taxes were $109000.0 in Q4 2024, -$100000.0 in Q3 2024, and -$64000.0 in Q2 2024.